96826 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
DIPHTHERIA-TETANUS-PERTUSSIS COMPOUND ADJUVANT COMBINED VACCINE
#2Bordetella T Cells Epitopes, Megapools and Uses Thereof
#3METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE
#4OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS
#5WHOOPING COUGH ANTIGEN RECOMBINANT EXPRESSION VECTOR, AND ENGINEERED STRAIN AND USE THEREOF
#6Attenuated Bordetella Strains
#7A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA
#8Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins
#9Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#10Mutant Bordetella Strains and Methods of Use
#11Kit and method for constructing long-acting depression animal model
#12METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE
#13Attenuated Bordetella Strains
#14FERMENTATION PROCESS
#15Production of soluble recombinant proteins without N-terminal methionine in
#16METHODS AND COMPOSITIONS FOR IMPROVING ENGINEERED MICROBES
#17Surface display of antigens on Gram-negative outer membrane vesicles
#18Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#19Expression and purification of CRM proteins and related proteins, and protein domains
#20Monomeric and functional adenylate cyclase CyaA toxin
#21Surface display of antigens on gram-negative outer membrane vesicles
#22Engineered programmable molecular scaffolds from porous protein crystals
#23Pertussis vaccines and methods of making and using
#24CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses
#25Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
#26outer-membrane protein antigens and methods of making and using the same
#27GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES
#28Cupredoxin derived transport agents and methods of use thereof
#29Compositions and methods to prevent cancer with cupredoxins
#30HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS
#31HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders
#32Recombinant strains
#33CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses
#34outer-membrane protein antigens and methods of making and using the same
#35ACELLULAR PERTUSSIS VACCINE
#36Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
#37Fermentation process for producing a virulence factor from bordetella
#38Modified strains
#39COMPOSITIONS AND METHODS TO CONCURRENTLY TREAT AND/OR PREVENT MULTIPLE DISEASES WITH CUPREDOXINS
#40Effect of an attenuated strain against allergic disease
#41Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
#42Methods for purifying pertussis toxin and peptides useful therefor
#43Cupredoxin derived transport agents and methods of use thereof
#44ENGINEERED PERTACTIN VARIANTS FOR VACCINE USE
#45Mucosal adjuvant composition
#46Compositions and methods to prevent cancer with cupredoxins
#47Cupredoxin derived transport agents and methods of use thereof
#48Nucleic acids encoding GAS57 mutant antigens
#49Compositions and methods to prevent cancer with cupredoxins
#50Compositions and Methods for Modulating a Cytotoxic T Lymphocyte Immune Response
#51POLYPEPTIDE CARRIER PROTEIN
#52High level expression of recombinant toxin proteins
#53Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
#54GAS57 mutant antigens and GAS57 antibodies
#55Engineered pertactin variants for vaccine use
#56Malonate decarboxylases for industrial applications
#57outer-membrane protein antigens and methods of making and using the same
#58Non-toxic double mutant forms of pertussis toxin as adjuvants
#59Cupredoxin derived transport agents and methods of use thereof
#60Compositions and methods to prevent cancer with cupredoxins
#61Method of separating protective components of bordetella pertussis
#62Polypeptide carrier protein
#63Methods for purifying pertussis toxin and peptides useful therefor
#64Antibiotic compositions and related screening methods
#65METHOD OF SEPARATING PROTECTIVE COMPONENTS OF BORDETELLA PERTUSSIS
#66ORAL PERTUSSIS VACCINE AND METHOD FOR PRODUCING PERTUSSIS VACCINE
#67Iron-Containing Human Milk Fortifier With Improved Antimicrobial Properties
#68Deacylation of LPS in gram negative bacteria
#69Compositions and methods to prevent cancer with cupredoxins
#70Compositions and methods to prevent cancer with cupredoxins
#71Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
#72Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens
#73Polyepitope carrier protein
#74Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly)
#75Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
#76Formulations and process for production of Bordetella bronchiseptica P68 antigen and vaccines
#77Method for the production of bacterial toxins
#78Method for the production of bacterial toxins
#79Pertussis toxin gene: cloning and expression of protective antigen
#80Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
#81High yield pertussis vaccine production strain and method for making same
#82Cupredoxin derived transport agents and methods of use thereof
#83Acellular antibordetella vaccine
#84Polypeptides containing polymorphisms of the repeated regions of pertactin in , and , their use in diagnostics, and in immunogenic compositions
#85Immunologically active peptides with altered toxicity useful for the preparation of antipertussis vaccine
#86Compositions and methods for modulating a cytotoxic T lymphocyte immune response
#87Defective entities and uses therefor
#88Method of separating protective components of bordetella pertussis
#89Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form
#90Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
#91Method for the production of bacterial toxins